Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou do not need to exercise on Mounjaro for the medicine to work, but physical activity meaningfully improves your results and your health beyond weight loss alone. Mounjaro's licence requires it to be used alongside a reduced-calorie diet and increased physical activity — 'increased' being the operative word, not 'intensive'. The decision about how much exercise to do is one of degree and personal circumstance, not a binary yes or no. This page lays out the factors so you can think it through clearly, and so that the conversation with your prescriber starts in the right place.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) is licensed in the UK as a treatment for weight management in adults, to be used alongside a reduced-calorie diet and increased physical activity. That phrase comes directly from the product's authorised indication. What it does not say is that you must reach a particular step count, run a certain distance, or attend the gym. The licensing language sets a direction of travel, not a finish line.
For many people reading this, that distinction matters. You might be managing joint pain, recovering from surgery, or living with a condition that limits what your body can currently do. Feeling anxious about whether that disqualifies you from treatment is completely understandable, and it is one of the questions our prescribers hear regularly. The short answer is that immobility or limited capacity for exercise does not automatically make you unsuitable; your whole clinical picture is what your prescriber weighs up.
A useful framing is this: the licence asks you to move more than you currently do, in whatever way is accessible to you. For someone who is largely sedentary, a daily ten-minute walk after dinner counts. For someone already active, the bar is higher. The clinical trial participants (thousands of adults across the SURMOUNT programme) were not elite exercisers. They followed lifestyle guidance, and the results were still significant. The NHS medicines page for tirzepatide echoes this: lifestyle changes work alongside the medicine, not as a prerequisite to it.
The more useful question is not whether you need to exercise on Mounjaro, but what you lose if you skip it. There are three areas where physical activity earns its place.
First, it protects muscle. When you lose weight quickly (and tirzepatide can drive meaningful losses in a relatively short period) your body does not discriminate neatly between fat and lean tissue. Resistance training, or even brisk walking, signals to the body that muscle is worth keeping. Losing muscle alongside fat slows your resting metabolism and makes weight maintenance harder afterward.
Second, it improves cardiovascular and metabolic health in ways that appetite suppression alone cannot. Blood pressure, insulin sensitivity, mood and sleep all respond to movement. For people with weight-related conditions such as type 2 diabetes or hypertension (the very conditions that may have influenced their eligibility) these benefits matter independently of the number on the scale.
Third, it supports the psychological shift that tends to accompany long-term weight management. Movement that feels achievable builds a different relationship with your body than crash dieting does. If you are thinking about whether you should exercise on Mounjaro and what the considerations actually are, it is worth reading through before you settle on a routine. You can also explore how exercise and Mounjaro interact practically to think through what that might look like for you.
None of this means you need to overhaul your life before you start treatment. It means that adding movement (even modestly) compounds the benefit.
There is a specific group of people for whom this question is not about preference but about physical reality. Severe osteoarthritis, chronic back pain, recent surgery, or a disability can make conventional exercise impossible or unsafe. This is more common among people seeking Mounjaro than clinical trial recruitment would suggest, because the people most likely to qualify for treatment are often those whose weight has already affected their joints and mobility.
The honest answer is that Mounjaro can still work without exercise, though results are generally better with it. The SURMOUNT-1 data, published in the New England Journal of Medicine, showed average body-weight reductions of around 20% at the 15mg dose over 72 weeks, a striking figure even allowing for the fact that trial participants had lifestyle support. Participants who engaged more consistently with activity guidance tended to see better outcomes, but the medicine's mechanism of suppressing appetite and slowing gastric emptying does its job regardless.
If your mobility is limited, the right move is to tell your prescriber exactly that, and to discuss what 'increased activity' realistically means for your situation. A chair-based routine, swimming, or physiotherapy-led movement may all qualify. What matters is the intention and the direction, not the intensity.
If you are weighing up whether it is possible to lose weight on Mounjaro without exercising, the evidence suggests yes, though the combination of medicine and movement consistently outperforms either alone.
The most practical thing you can do is decide, before you begin treatment, what 'increased activity' means for you specifically. Not an aspirational answer, but an honest one. Two walks a week becomes three. Fifteen minutes of stretching becomes a habit. The goal is sustainability over the course of treatment, which is measured in months, not weeks.
Mounjaro reduces appetite substantially for most people. That reduced hunger can make it tempting to eat very little and rest entirely. A prescriber reviewing your care will generally encourage you to protect your protein intake and keep moving, precisely because those two things safeguard what you are building, not just the weight loss, but the health underneath it. Our overview of building an exercise plan around Mounjaro covers the practical side in more detail, including timing relative to your injection day.
You might also find it helpful to read about eating patterns on Mounjaro, since nutrition and activity work as a pair. And if you want to understand the full clinical picture of tirzepatide as a medicine, the tirzepatide overview is a good starting point.
If you are ready to talk through your situation with a prescriber, a free consultation with our clinical team is the straightforward next step. There are no targets to hit before you apply, the consultation is where you and a prescriber work out what is realistic together.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.